Germany leads in global cardiovascular system medicine use with 836.6 units per thousand persons per day, followed by Denmark (703.2) and Sweden (624.4). Notable year-on-year variations include a 10.74% increase in Chile and a 5.53% rise in South Korea, while Luxembourg saw a decline of 2.36%. Over the past five years, consistent increases have been observed, except for Luxembourg. The Compound Annual Growth Rate (CAGR) has shown modest but steady growth across most countries, signifying an overall upward trend in medication use.
Future trends to watch include the continued increase in cardiovascular medicine use in developing countries like Chile, and potential policy changes in countries showing slower growth or declines. Innovations in treatment, aging populations, and lifestyle factors will play significant roles in shaping these trends.
Top countries in Cardiovascular System Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 836.6 | 2023 | +2.21% | +3.05% | View data |
| 2 | 2 Denmark | 703.2 | 2023 | +3.67% | +4.37% | View data |
| 3 | 3 Sweden | 624.4 | 2023 | +4.38% | +3.75% | View data |
| 4 | 4 Chile | 608.2 | 2023 | +1.15% | +10.74% | View data |
| 5 | 5 Lithuania | 535.5 | 2023 | +1.34% | +3.22% | View data |
| 6 | 6 Canada | 512.6 | 2023 | +0.93% | +2.13% | View data |
| 7 | 7 Italy | 508.1 | 2023 | +0.51% | +0.84% | View data |
| 8 | 8 Belgium | 488.4 | 2023 | +0.51% | +0.57% | View data |
| 9 | 9 Spain | 473.2 | 2023 | +0.79% | +1.25% | View data |
| 10 | 10 New Zealand | 473 | 2023 | +2.65% | View data |
